1:5 Stock Split Confirmed – Will This Make IOL Chemicals More Affordable For Investors?

Founded in 1986, it is listed on both the BSE Ltd. and the National Stock Exchange of India Ltd. With top-notch facilities, IOL Chemicals & Pharmaceuticals Ltd (IOLCP) is a major player in the speciality chemicals market and one of the top pharmaceutical (API) companies. In several important therapeutic areas, including pain management, anti-convulsants, anti-diabetes, anti-cholesterol, and anti-platelets, IOLCP is widely used. The company is the world's largest producer of Ibuprofen with an installed capacity of 12,000 TPA and featuring a fully integrated manufacturing facility. Among the numerous nations where IOLCP has clients abroad are the United Kingdom, Belgium, Hungary, Spain, Germany, Italy, the Netherlands, Switzerland, Poland, Ireland, the United States, Peru, Brazil, Argentina, Colombia, Indonesia, South Korea, Thailand, Bangladesh, Turkey, the United Arab Emirates, China, Hong Kong, and Egypt, among others.

IOL Chemicals & Pharmaceuticals Stock Split

"This is in continuation to our earlier letter dated 7th February 2025 regarding intimation of Record Date of 11th March 2025 for Sub-division/ split of existing Equity Shares of the Company from 1 (One) Equity Share having face value of Rs. 10/- (Rupees Ten Only) each, fully paid-up, into 5 (Five) Equity Shares having face value of Re. 2/- (Rupee Two Only) each, fully paid-up. In this regard, we wish to inform you that National Securities Depository Limited (NSDL) and Central Depository Services Limited (CDSL) have assigned a new ISIN i.e. INE485C01029 for equity shares of face value of Rs 2 each. The new ISIN will be effective from Tuesday, 11th March 2025 ("Record Date")," said IOL Chemicals & Pharmaceuticals in a stock exchange filing.

IOL Chemicals & Pharmaceuticals News

"We are pleased to inform you that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company's API product "Quetiapine Fumarate" on 4th March 2025. This certification will enable the Company to export Quetiapine Fumarate to European and other countries that accept CEPs. Quetiapine Fumarate is an antipsychotic drug which is widely used to treat various mental health disorders," informed IOL Chemicals & Pharmaceuticals to stock exchanges on 5th March 2025.

IOL Chemicals Share Price Target

Hardik Matalia - Derivative Analyst at Choice Broking said, "IOLCP is currently trading at ₹345.70, experiencing a prolonged downtrend and forming a descending channel pattern. The stock has faced consistent selling pressure, staying below its key Exponential Moving Averages (EMAs) (20, 50, 200). However, it recently attempted a bounce from its lower levels, indicating a potential short-term reversal."

" For a trend reversal, the stock needs to break out of the descending channel and sustain above the ₹360-₹365 zone, which aligns with the 50-day EMA. A decisive close above this level could trigger further upside towards the ₹395-₹400 range, where the 200-day EMA is positioned. On the downside, ₹325 remains a key support, and a breakdown below this level could lead to further weakness toward ₹300," the analyst added.

"The Relative Strength Index (RSI) is at 49.88, rebounding from oversold levels and trending upwards, indicating support for potential upward momentum. Traders should wait for a breakout confirmation, while investors may consider accumulating at current levels and on dips, provided the stock sustains above key support zones," Hardik Matalia further commented.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.